Cargando…

YAP1 is essential for malignant mesothelioma tumor maintenance

Malignant pleural mesothelioma, a tumor arising from the membrane covering the lungs and the inner side of the ribs, is a cancer in which genetic alterations of genes encoding proteins that act on or are part of the Hippo-YAP1 signaling pathway are frequent. Dysfunctional Hippo signaling may result...

Descripción completa

Detalles Bibliográficos
Autores principales:	Calvet, Loreley, Dos-Santos, Odette, Spanakis, Emmanuel, Jean-Baptiste, Véronique, Le Bail, Jean-Christophe, Buzy, Armelle, Paul, Pascal, Henry, Christophe, Valence, Sandrine, Dib, Colette, Pollard, Jack, Sidhu, Sukhvinder, Moll, Jürgen, Debussche, Laurent, Valtingojer, Iris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188206/ https://www.ncbi.nlm.nih.gov/pubmed/35689194 http://dx.doi.org/10.1186/s12885-022-09686-y

Ejemplares similares

TEAD Inhibitors Sensitize KRAS(G12C) Inhibitors via Dual Cell Cycle Arrest in KRAS(G12C)-Mutant NSCLC
por: Tammaccaro, Salvina Laura, et al.
Publicado: (2023)

Targeting YAP in malignant pleural mesothelioma
por: Zhang, Wen‐Qian, et al.
Publicado: (2017)

Genome-wide CRISPR Screen Reveals RAB10 as a Synthetic Lethal Gene in Colorectal and Pancreatic Cancers Carrying SMAD4 Loss
por: Erasimus, Hélène, et al.
Publicado: (2023)

High Glucose Activates YAP Signaling to Promote Vascular Inflammation
por: Ortillon, Jeremy, et al.
Publicado: (2021)

The Biology of Malignant Mesothelioma and the Relevance of Preclinical Models
por: Blanquart, Christophe, et al.
Publicado: (2020)

Editorial: Focus on malignant pleural mesothelioma immunology and immunotherapy
por: Porta, Chiara, et al.
Publicado: (2023)

Dropwort-induced metabolic reprogramming restrains YAP/TAZ/TEAD oncogenic axis in mesothelioma
por: Pulito, Claudio, et al.
Publicado: (2019)

Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP
por: Dubois, Fatéméh, et al.
Publicado: (2022)

Peptidomics of Haemonchus contortus
por: Buzy, Armelle, et al.
Publicado: (2021)

Recent Therapeutic Approaches to Modulate the Hippo Pathway in Oncology and Regenerative Medicine
por: Barry, Evan R., et al.
Publicado: (2021)

Analysis of YAP1 and TAZ expression by immunohistochemical staining in malignant mesothelioma and reactive mesothelial cells
por: Takehara, Yusuke, et al.
Publicado: (2018)

Analysis of YAP1 and TAZ expression by immunohistochemical staining in malignant mesothelioma and reactive mesothelial cells
por: Takehara, Yusuke, et al.
Publicado: (2018)

YAP/TAZ activation predicts clinical outcomes in mesothelioma and is conserved in in vitro model of driver mutations
por: Cunningham, Richard, et al.
Publicado: (2023)

Aberrant expression of NPPB through YAP1 and TAZ activation in mesothelioma with Hippo pathway gene alterations
por: Sato, Tatsuhiro, et al.
Publicado: (2023)

Potentiation of imatinib by cilostazol in sensitive and resistant gastrointestinal stromal tumor cell lines involves YAP inhibition
por: Vandenberghe, Pierre, et al.
Publicado: (2019)

Ferroptosis Induction and YAP Inhibition as New Therapeutic Targets in Gastrointestinal Stromal Tumors (GISTs)
por: Delvaux, Marine, et al.
Publicado: (2022)

Hyaluronic acid enhances cell migration and invasion via the YAP1/TAZ-RHAMM axis in malignant pleural mesothelioma
por: Shigeeda, Wataru, et al.
Publicado: (2017)

Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival
por: Quetel, Lisa, et al.
Publicado: (2020)

SAR110894, a potent histamine H3-receptor antagonist, displays disease-modifying activity in a transgenic mouse model of tauopathy
por: Delay-Goyet, Philippe, et al.
Publicado: (2016)

Determinants of malignant pleural mesothelioma survival and burden of disease in France: a national cohort analysis
por: Chouaid, Christos, et al.
Publicado: (2018)

Histologic Assessment of Drug-Eluting Grafts Related to Implantation Site
por: Tille, Jean-Christophe, et al.
Publicado: (2016)

Análisis de la ley de seguridad interior /
por: Avendaño Naranjo, Loreley
Publicado: (2018)

Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma
por: Blondy, Thibaut, et al.
Publicado: (2020)

Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma
por: Bensaid, Douae, et al.
Publicado: (2018)

Synergistic activity and heterogeneous acquired resistance of combined MDM2 and MEK inhibition in KRAS mutant cancers
por: Hata, Aaron N, et al.
Publicado: (2017)

Heterogeneous RNA editing and influence of ADAR2 on mesothelioma chemoresistance and the tumor microenvironment
por: Hariharan, Ananya, et al.
Publicado: (2022)

Is adherence a relevant issue in the self-management education of diabetes? A mixed narrative review
por: Debussche, Xavier
Publicado: (2014)

Health literacy in context: struggling to self-manage diabetes – a longitudinal qualitative study
por: Debussche, Xavier, et al.
Publicado: (2022)

Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition
por: Srinivasan, Gayathri, et al.
Publicado: (2017)

Mesothelioma
por: Rao, Nagarjun, et al.
Publicado: (2022)

Mesothelioma
por: Deraco, Marcello
Publicado: (2021)

NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural Mesothelioma
por: Yang, Haitang, et al.
Publicado: (2021)

A defect of amphiregulin release predicted longer survival independently of YAP expression in patients with pleural mesothelioma in the IFCT‐0701 MAPS phase 3 trial
por: Maille, Elodie, et al.
Publicado: (2022)

Deep dive into the immune response against murine mesothelioma permits design of novel anti-mesothelioma therapeutics
por: Stern, Esther, et al.
Publicado: (2023)

KRAS signaling in malignant pleural mesothelioma
por: Marazioti, Antonia, et al.
Publicado: (2021)

Targeting SRC Family Kinases in Mesothelioma: Time to Upgrade
por: Indovina, Paola, et al.
Publicado: (2020)

Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions
por: Alcala, Nicolas, et al.
Publicado: (2019)

Transforming Growth Factor β/activin signalling induces epithelial cell flattening during Drosophila oogenesis
por: Brigaud, Isabelle, et al.
Publicado: (2015)

Amotl1 mediates sequestration of the Hippo effector Yap1 downstream of Fat4 to restrict heart growth
por: Ragni, Chiara V., et al.
Publicado: (2017)

IL‐7 is expressed in malignant mesothelioma and has a prognostic value
por: Mai, Hoa‐Le, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fmnm2065ooivebmcs69grq0rff